Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SMM | News: SMM Summit Resources Enters Bid Implementation Agreement With Paladin Energy | 07:01 | 1 | 2.4K | |||
|
|||||||
SMM | Ann: Removal from Official List | 23/10/18 | 0 | 1.2K | |||
|
|||||||
SMM | Ann: PDN: Close of Paladin Offer for Summit | 22/10/18 | 0 | 1.5K | |||
|
|||||||
SMM | Ann: Suspension from Official Quotation | 18/10/18 | 0 | 527 | |||
|
|||||||
SMM | Ann: Notice of Status of Conditions from PDN | 12/10/18 | 0 | 960 | |||
|
|||||||
SMM | Ann: PDN: Paladin to commence compulsory acquisition of Summit | 11/10/18 | 0 | 876 | |||
|
|||||||
SMM | Ann: Notice of Annual General Meeting and Proxy Form | 08/10/18 | 0 | 948 | |||
|
|||||||
SMM | Ann: PDN:Summit takeover offer free from conditions | 08/10/18 | 0 | 1.0K | |||
|
See All Discussions